Tumor vascularity as a prognostic indicator in intermediate-thickness (0.76-4 mm) Cutaneous melanoma: A quantitative assay

American Journal of Dermatopathology

Volumn 18, Issue 5, 1996, Pages 474-477

  Rongioletti, Franco ^a,d   Miracco, Clelia ^b   Gambini, Claudio ^c   Pastorino, Angela ^b   Tosi, Pietro ^c   Rebora, Alfredo ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c GALLIERA HOSPITAL   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Angiogenesis; CD31; Melanoma; Tumor vascularity

Indexed keywords

CD3 ANTIGEN;

ADULT; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MELANOMA; METASTASIS; PRIORITY JOURNAL; TUMOR VASCULARIZATION; TUMOR VOLUME;

FEMALE; HUMANS; MALE; MELANOMA; PROGNOSIS; SKIN NEOPLASMS;

EID: 0029859698     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-199610000-00005     Document Type: Article

References (11)

1. Folkman J. Tumor angiogenesis. Adv Cancer Res 1974;19:331-58.
2. Miettinen M, Lindenmayer AE, Chaubal A. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens: evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol 1994;7:82-90.
3. Berger R. Albelda SM, Berd D, Ioffreda M, Whitaker D, Murphy GF. Expression of platelet endothelial cell adhesion molecule-1 (PECAM-1) during melanoma-induced angiogenesis in vivo. J Cutan Pathol 1993;20:399-406.
4. Weibel ER. Stereological methods. Vol. I. Practical methods for biological morphometry. London: Academic Press, 1979:378-9.
5. Horak ER, Leek R, Klenk N, Lejeune S, Smith K, Stuart N, Greenall M, Stepniewska K, Harris AL. Angiogenesis assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 1992;340:1120-4.
6. Marasa' L, Tomasino RM. Melanoma cutaneo. II. Proposta di un nuovo parametro prognostico: la valutazione dell'angiogenesi neoplastica. Pathologica 1983;75:353-65.
7. Srivastava A, Laidler P, Davies RP, Horgan K, Hughes LE. The prognostic significance of tumor vascularity in intermediate thickness (0.76-4.0 mm thick) skin melanoma: a quantitative histologic study. Am J Pathol 1988;133:419-23.
8. Barnhill RL, Mihm MC Jr, Ceballos PI. Angiogenesis and regressing cutaneous malignant melanoma. Lancer 1992;339:991-2.
9. Glass LF, Guffey JM, Schroer KR, Reintgen D. Immunohistochemical assessment of tumor vascularity in recurrent Clark level II melanomas using antibody to type IV collagen. J Cutan Pathol 1994;21:542.
10. Barnhill RL, Busam KJ, Berwick M, Blessing K, Cochran AJ, Elder DE, Fandrey K, Karaoli T, White WL. Tumour vascularity is not a prognostic factor for cutaneous melanoma. Lancet 1994;344:1237-8.
11. Barnhill RL, Fandrey K, Levy MA, Mihm MC Jr, Hyman B. Angiogenesis and tumor progression of melanoma: quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma. Lab Invest 1992;67:331-7.